How should chronic medical‑adhesive‑related skin damage be managed in a patient using Calmoseptine (menthol‑zinc oxide) topical ointment applied to the buttocks and groin after each shift for erythema?

Management of Chronic Medical Adhesive-Related Skin Damage with Calmoseptine

Continue using Calmoseptine (menthol-zinc oxide) ointment as prescribed, but optimize the application frequency to up to 6 times daily per FDA labeling rather than "every shift," and add barrier protection strategies to prevent ongoing adhesive trauma while treating the existing erythema.

Current Regimen Assessment

Your patient is appropriately using a zinc oxide-based barrier ointment, which is FDA-approved for application up to 6 times daily or after each bowel movement 1. The zinc oxide (20.6%) and petrolatum (24%) components provide both astringent and protective properties that are clinically beneficial for irritated skin 1, 2.

Key Management Principles for Chronic MARSI

Immediate Skin Care Optimization

• Cleanse gently before each application using mild soap and warm water, then pat dry completely before applying Calmoseptine 1
• Apply liberally to affected buttocks and groin areas—the zinc oxide formulation has demonstrated effective transfer to skin and reduction in erythema with continuous use 2
• Increase frequency if needed up to 6 times daily per FDA labeling, particularly if erythema persists 1

Address the Root Cause: Adhesive Selection

The chronic nature suggests ongoing adhesive trauma. Critical intervention: Identify and modify the medical adhesive devices causing injury 3, 4.

• Use minimal adhesive strength necessary for device function 5
• Consider silicone-based adhesives over acrylic-based products—they cause less skin stripping
• Apply skin barrier films (e.g., cyanoacrylate-based) to intact skin BEFORE adhesive application 3, 4
• Ensure proper application technique: avoid tension, smooth application without wrinkles 6

Proper Adhesive Removal Technique

This is where most damage occurs in chronic MARSI:

• Remove adhesives parallel to skin surface at 180-degree angle, supporting skin with other hand 6, 4
• Use medical adhesive removers (silicone-based) to dissolve adhesive before removal 3, 6
• Never pull perpendicular to skin—this causes skin stripping 4

Escalation Strategy if Erythema Persists

If erythema does not improve within 2 weeks despite optimized Calmoseptine use:

Add Topical Corticosteroid

• Apply hydrocortisone 1-2.5% ointment (mild potency) to erythematous areas twice daily for 2-3 weeks 7, 8
• Use ointment formulation rather than cream for better barrier protection in groin area 7
• Apply corticosteroid first, then Calmoseptine as barrier layer on top

Monitor for Complications

• Bacterial superinfection: Look for crusting, weeping, or worsening despite treatment—requires topical or oral antibiotics 7
• Fungal infection: Common in groin—treat with antifungal if suspected 9
• Contact dermatitis: If worsening with treatment, consider allergy to product components 10

Critical Pitfalls to Avoid

⚠️ Do NOT use alcohol-containing products on inflamed skin—they worsen barrier damage 7

⚠️ Do NOT apply adhesives directly over erythematous skin—use alternative securement methods or protective barriers 3, 4

⚠️ Do NOT use occlusive dressings in groin area without addressing moisture—increases maceration risk 7

⚠️ Avoid hot water and excessive soap—use lukewarm water and soap substitutes 7, 11

Documentation and Monitoring

• Assess skin daily before each adhesive application using standardized tool (e.g., body surface area affected, presence of skin stripping, tension blisters, or contact dermatitis) 12, 3
• Photograph lesions for objective monitoring 12
• Document adhesive products used and their location to identify patterns 13, 4

When to Escalate Care

Refer to dermatology if:

• Erythema progresses to blistering, erosions, or ulceration 7, 8
• No improvement after 2-4 weeks of optimized treatment 7, 8
• Suspected allergic contact dermatitis requiring patch testing 10
• Skin breakdown affects >10% body surface area 12

Long-term Prevention Strategy

The goal is preventing recurrent injury while maintaining necessary medical device securement 3, 4:

1. Risk stratification: Patients with thin/fragile skin, edema, or requiring multiple devices are highest risk 14, 15
2. Prophylactic barriers: Apply Calmoseptine to high-risk areas even before erythema develops 2, 4
3. Rotate adhesive sites when possible to allow skin recovery 6, 4
4. Staff education: Ensure all caregivers understand proper adhesive application/removal techniques 6, 4, 16